Boehringer Ingelheim Pharma GmbH & Co. KG
UkraineAll drugs from this manufacturer
-
The drug is used for the prevention and symptomatic treatment of shortness of breath in chronic obstructive airway diseases, such as bronchial asthma (allergic and non-allergic) and chronic obstructive bronchitis with or without emphysema. It also helps to prepare the lungs for further therapy with other medications.
Dosage form: aerosol, metered
Active substance Dosage ipratropium bromide 20 mcg fenoterol 50 mcg ATC: R03AL01
-
The drug is used for the symptomatic treatment of acute asthma attacks, prevention of exercise-induced asthma, as well as for the treatment of other conditions involving airway narrowing (e.g., obstructive bronchitis with emphysema).
Dosage form: aerosol, metered
Active substance Dosage fenoterol 100 mcg ATC: R03AC04
-
The drug is used for thrombolytic therapy in adults with suspected myocardial infarction (with persistent ST-segment changes or recent left bundle branch block) within 6 hours of symptom onset.
Dosage form: lyophilisate for solution for injection
Active substance Dosage tenecteplase 10 000 IU or 50 mg ATC: B01AD11
-
The drug is prescribed to adults for the treatment of arterial hypertension (high blood pressure), as well as for the prevention of cardiovascular diseases in patients with ischemic heart disease, stroke, peripheral artery disease, or type 2 diabetes mellitus with target organ damage.
Dosage form: tablets
Active substance Dosage telmisartan 80 mg ATC: C09CA07
-
The drug is prescribed to adults for the treatment of signs and symptoms of Parkinson's disease (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate or severe restless legs syndrome.
Dosage form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
-
The drug is prescribed to adults for the treatment of signs and symptoms of Parkinson's disease (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate or severe restless legs syndrome.
Dosage form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
-
The drug is prescribed for the primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip or knee replacement surgery.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC: B01AE07
-
The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis and pulmonary embolism, as well as for the prevention of recurrent cases of these diseases. Additionally, Pradaxa is used for the primary prevention of thrombosis following elective hip or knee replacement surgery.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC: B01AE07
-
The drug is prescribed for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (in the presence of risk factors such as age 75 or older, diabetes, hypertension, etc.), as well as for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC: B01AE07
-
The drug is used for maintenance bronchodilator therapy to relieve symptoms in chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation, hard capsules
Active substance Dosage tiotropium 18 mcg ATC: R03BB04
-
The drug is used for maintenance therapy to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD). It is also prescribed as add-on maintenance therapy for adults and children from 6 years of age with severe asthma who have had serious exacerbations within the last year.
Dosage form: solution, for inhalation
Active substance Dosage tiotropium bromide 2.5 mcg/inhalation ATC: R03BB04